Balto Pharmaceuticals
PrivateLast Round
Seed
Aug 30, 2023
Total Funding Raised
$2M
Company Overview
Balto Pharmaceuticals is a biotechnology company that develops small molecule inhibitors targeting protein-protein interactions for the treatment of cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Balto Pharmaceuticals Comparables
Compare Balto Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SyntheX | 85% | |
| Ambagon Therapeutics | 85% | |
| Magnet Biomedicine | 85% |
Balto Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 30, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 30, 2023
$2M round completed.
Balto Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Balto Pharmaceuticals's valuation, stock price, and market status.
Is Balto Pharmaceuticals a public or private company?
Balto Pharmaceuticals is a private company.
What is the current stock price of Balto Pharmaceuticals?
Balto Pharmaceuticals is a private company with no public stock price. Caplight tracks Balto Pharmaceuticals's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Balto Pharmaceuticals worth (valuation)?
Valuation information for Balto Pharmaceuticals is not publicly available.
Can I buy Balto Pharmaceuticals stock?
Balto Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Balto Pharmaceuticals's last funding round?
Balto Pharmaceuticals's most recent funding round was Seed on August 30, 2023.
Who are the main investors in Balto Pharmaceuticals?
Investor information for Balto Pharmaceuticals is not publicly disclosed.
Will Balto Pharmaceuticals IPO soon?
No public IPO plans have been announced for Balto Pharmaceuticals.
How can I track Balto Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Balto Pharmaceuticals's secondary market activity and sign up for updates.